Prescription rule changes to support telehealth
Australia’s Chief Health Officer has approved an amendment to PBS prescription requirements for telehealth consultations as an emergency measure during the COVID-19 response.
Could this medicine revolutionise schizophrenia treatment?
Working on a new mechanism of action, this treatment could change the lives of patients with schizophrenia. But not all patients can take it.
Date of birth now required on all NSW scripts
From 1 November 2022, the date of birth of every patient must be included on all prescriptions for Schedule 4 and Schedule 8 medicines.
How to save a life with naloxone
By providing non-judgemental and appropriate counselling on the use of naloxone, pharmacists can empower those who carry it to confidently intervene in the case of opioid toxicity.
The 6 situations when photo ID is required
Checking a patient's photo identification (ID) can be both a useful – and mandatory – practice.
Australian Pharmacist explores the instances where minimum practice and...
Efficacy and safety of diclofenac for the management of pain
Pharmacists are well equipped to assist patients who request treatment for pain. This article discusses the role of the pharmacist in the appropriate supply of over-the-counter diclofenac for management of pain.
